跳至主要内容
临床试验/ACTRN12615001304527
ACTRN12615001304527已完成2 期

In children requiring surgical repair of congenital cardiac defects, does the use of Dexmedetomidine as the primary sedative agent compared to Midazolam reduce the length of mechanical ventilation and PICU length of stay.

Paediatic Critical Care Research Group0 个研究点目标入组 66 人开始时间: 2015年11月30日最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
66

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
o limit 至 12 Months(—)
性别
All

入选标准

  • 1. The patient is undergoing surgical repair of a congenital heart defect requiring cardiopulmonary bypass and will require mechanical ventilation via an endotracheal tube post-operatively, and the treating clinician believes that:
  • 2.The patient will require immediate post-operative AND ongoing sedative medication for comfort, safety, and to facilitate the delivery of life support measures.
  • 3.The patient is expected to remain intubated post-operatively.

排除标准

  • 1. Age > 12 months
  • 2. Proven or suspected acute primary brain lesion that may result in global impairment of conscious level or cognition, such as traumatic brain injury, intracranial haemorrhage, intracranial infection or hypoxic brain injury.
  • 3. Allergy to dexmedetomidine

研究者

发起方
Paediatic Critical Care Research Group

相似试验

招募中
不适用
Follow-up of infants and children surgically treated for an acquired laryngeal stenosis after endotracheal intubatioverworven luchtwegaandoeningenlarynxstenosisnarrowing of the upper airway
NL-OMON34296Erasmus MC, Universitair Medisch Centrum Rotterdam79
尚未招募
不适用
Research on the recovery of children with congenital muscular torticollis after treatment with Chanrou Tuinacongenital muscular torticollis
ITMCTR2200006403Second Teaching Hospital of Tianjin University of Traditional Chinese Medicine
招募中
2 期
Treatment of congenital vascular malformations using Sirolimus: improving quality of Life
NL-OMON45838Radboud Universitair Medisch Centrum75
进行中(未招募)
1 期
Treatment of congenital vascular malformations with Sirolimuscongenital vascular malformation : Vascular malformationscan involve lymphatic vessels, capillaries, veins and arteries or even combinations. These vascularmalformations are present at birth and grow with the child.MedDRA version: 20.0Level: HLTClassification code 10047091Term: Vascular malformations and acquired anomaliesSystem Organ Class: 100000005125MedDRA version: 20.0Level: LLTClassification code 10047090Term: Vascular malformation peripheralSystem Organ Class: 100000158692MedDRA version: 20.0Level: PTClassification code 10070181Term: Gastrointestinal vascular malformationSystem Organ Class: 10017947 - Gastrointestinal disordersMedDRA version: 20.0Level: PTClassification code 10074979Term: Vascular malformationSystem Organ Class: 10010331 - Congenital, familial and genetic disorders
EUCTR2016-002157-38-NLRadboud University Medical Center75
已完成
不适用
PAH-CHD predominantly Lt-Rt shunt with borderline PVR and ESData of outcomes in patients who had PAH-CHD (confirmed by dignostic cardiac catheterization) with borderline pulmonary vascular resistance (PVR) and recieved directed targeted therapy prior to surgicPulmonary arterial hypertension, Congenital heart disease, treat and repair
TCTR20200420004Faculty of Medicine432